暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
HUGE FSD Pharma
- 0.3754
- -0.0321-7.88%
收盘价 05/01 16:00 (美东)
- 0.3600
- -0.0154-4.10%
盘后 19:57 (美东)
1517.73万总市值-816市盈率TTM
0.4299最高价0.3557最低价65.89万股成交量0.4200今开0.4075昨收25.31万成交额1.90%换手率亏损市盈率(静)4042.96万总股本1.679952周最高1.15市净率1300.85万流通值0.355752周最低--股息TTM3465.23万流通股14.0000历史最高--股息率TTM18.22%振幅0.3557历史最低0.3840平均价1股每手
全部分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
快讯 | “解密大麻仍使大麻库存陷入困境”-《华尔街日报》
FSD Pharma Trials 酒精中毒补充剂
缉毒局开始将大麻重新归类为危险性较低的药物
缉毒局开始将大麻重新归类为危险性较低的药物
FSD Pharma与应用科学与性能研究所签署协议，在美国进行一项临床试验，以评估 “Unbuzzd” 在酒精中毒诱发状态下的安全性和有效性
FSD Pharma Inc.（纳斯达克股票代码：HUGE）（CSE: HUGE）（FRA: 0K9A）（“公司” 的 “FSD Pharma”），一家致力于为该疗法建立创新资产和生物技术解决方案组合的生物制药公司
快讯 | 关注大麻股票的股票；交易员在TDR播客中发表评论说：“我们听说有传言称该公告可能在本周发布——不管做出什么决定”，“我从一些消息来源听说支持大麻的消息
FSD Pharma表示，Celly Nutrition与Six+One合作在美国推出膳食补充剂
FSD Pharma（HUGE）周四表示，Celly Nutrition已与品牌机构Six+One合作，合作在美国推出其膳食补充剂。作为合作的一部分，
评论
$FSD Pharma(HUGE.US$
NEWS
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
NEWS
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
$FSD Pharma(HUGE.US$ This sure was a disappointment! But its green! And thats sure better than red by any amount 
2
Update
$FSD Pharma(HUGE.US$ FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product Unbuzzd
Benzinga· 8 mins ago
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City.
FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving indiv...
Benzinga· 8 mins ago
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City.
FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving indiv...
$FSD Pharma(HUGE.US$
NEWS
FSD Pharma Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, giving them a 180-day compliance period to meet the requirement or face potential delisting.
NEWS
FSD Pharma Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, giving them a 180-day compliance period to meet the requirement or face potential delisting.
Update
$FSD Pharma(HUGE.US$ FSD Pharma Brief: Signed Agreement With INGENu CRO To Conduct a Clinical Study To Assess Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅